# MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

> clinical trial · VERIFIED · 2026-08-24

Status: RECRUITING · Sponsor: Eli Lilly and Company · Condition: Pancreatic Ductal Adenocarcinoma

- Company: Eli Lilly and Company
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06586515

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.